Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 645 of 6351
-
One shot before surgery: could early immunotherapy stop melanoma in its tracks?
Disease control Recruiting nowThis study, called NeoSenti, is exploring whether giving one dose of the immunotherapy drug pembrolizumab before surgery can help the immune system fight melanoma more effectively. The study includes adults with high-risk melanoma who do not show any signs of the cancer having sp…
Phase 2 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New mRNA flu vaccine trial aims to stop future pandemics
Vaccine OngoingThe purpose of this phase 1/2 study is to investigate the safety and immunogenicity of different doses (high, medium and low) of a second generation structurally designed (SD2) H5 messenger ribonucleic acid (mRNA) vaccine against pandemic H5 influenza virus (pandemic flu H5 hemag…
Phase 1/2 • Sponsor: Sanofi • Aim: Vaccine
Last updated Jun 27, 2026 08:12 UTC
-
Could a blood flow 'Tourniquet' workout repair diabetic nerve damage?
Symptom relief OngoingDiabetic peripheral neuropathy is one of the most prevalent complications of Type 2 Diabetes Mellitus. Peripheral neuropathy is caused by unavailability of glucose in cells and low metabolism. The Blood flow restriction training cause glucose diffusion into cell and Angiogenesis.
Sponsor: Superior University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Poop pills plus chemo: new combo tackles tough colon cancer
Disease control Recruiting nowThe investigators plan to initiate a prospective, multicenter, phase II study, recruiting 30 patients with advanced colon cancer patients with liver metastasis who have not received prior treatment. This study plans to reconstruct intestinal microecology through fecal microbiota …
Phase 2 • Sponsor: Hua Jiang • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New heart zapping technique could be safer for AF patients
Disease control Recruiting nowAtrial fibrillation (AF) is one of the most common arrhythmias in clinical practice. As of 2019, there were approximately 59.7 million patients with AF worldwide, including atrial flutter (AF). Atrial fibrillation can significantly increase the risks of stroke, thromboembolism an…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a simple hormone shield kidneys after liver transplant?
Disease control Recruiting nowLiver transplantation (LT) is a high-risk surgery for hemodynamic instability and haemorrhagic shock with a high-risk of acute kidney injury (AKI). Indeed, the incidence of post-transplant AKI exceeds 50% in some series with 15% of patients requiring renal replacement therapy. Ac…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New eye drug EYE103 takes on standard treatment for Diabetes-Related vision loss
Disease control OngoingEYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active control, ranibizumab, in patients with diabetic macular edema (DME). In the first year, all 3 treatment groups will be treated ev…
Phase 2/3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New bladder cancer combo shows promise in Pre-Surgery trial
Disease control Recruiting nowThe purpose of this Phase II, open-label, multicenter, randomized controlled study is to evaluate the efficacy and safety of Enfortumab Vedotin in combination with Toripalimab compared to Gemcitabine plus Cisplatin. This regimen is evaluated as a neoadjuvant treatment for patient…
Phase 2 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common drug stop a rare liver disease from returning after transplant?
Prevention Recruiting nowThis study aims to determine the efficacy of 36 months once-daily fenofibrate in preventing clinically-detectable recurrence of primary sclerosing cholangitis after liver transplantation, compared with a historical control cohort that was not treated with
Phase 2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Jul 19, 2026 00:00 UTC
-
Can a smarter heart map make risky ablation safer and more effective?
Disease control Recruiting nowThis is a multicenter, prospective, parallel, randomized controlled trial to test for non-inferiority with an ILAM-guided VT ablation compared to conventional voltage- based ablation. The study has two treatment arms: conventional voltage mapping and ablation (control arm). In th…
Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a daily supplement boost fertility? a new trial investigates
Disease control CompletedThis study evaluates the effects of a daily dietary supplement (WeNatal For Her) on markers of female fertility, reproductive health, and sexual health over three menstrual cycles. Forty female participants who are currently trying to conceive will take three capsules of the supp…
Sponsor: WeNatal • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Which breathing aid keeps patients off the ventilator longer?
Disease control CompletedAcute hypercapnic respiratory failure is characterized by elevated arterial carbon dioxide levels and commonly occurs in patients with chronic respiratory diseases. Patients with type II respiratory failure who experience difficult weaning from invasive mechanical ventilation are…
Sponsor: Benha University • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New pill for psoriasis shows promise in large trial
Disease control OngoingThe main purpose of this study is to assess how well JNJ-77242113 works when compared to placebo and ustekinumab in participants with moderate to severe plaque psoriasis.
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a gut supplement ease anxiety and depression in obesity?
Disease control Recruiting nowObese individuals are a particularly vulnerable population for mental health problems, especially depression and anxiety. The aim of this study is to evaluate whether the intake of a synbiotic, composed of prebiotics and beneficial intestinal bacterial strains, is capable of prod…
Sponsor: Celia Bañuls • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New combo therapy aims to tame thyroid eye disease
Disease control Recruiting nowThyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune disease closely related to thyroid disease, which leads the incidence of orbital disease in adults and is the most common cause of diffuse toxic goiter (Graves disease, GD). The clinical manifestations of TAO…
Phase 4 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:42 UTC
-
Glow-in-the-Dark dye could help surgeons find hidden tumors in kids
Diagnosis Recruiting nowThis phase III trial studies how well pafolacianine works for identifying cancerous lesions in children and adolescent patients with primary solid tumors or solid tumors that have spread from where they first started (primary site) to other places in the body (metastatic). Pafola…
Phase 3 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
New Antibody-Drug combo takes aim at Hard-to-Treat ovarian cancer
Disease control Recruiting nowResearchers are looking for other ways to treat high-grade serous and certain other ovarian cancer. High-grade means the cancer cells grow and spread quickly. Serous means the cancer started in the cells that cover the ovaries, the lining of the belly, or in the fallopian tubes. …
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New antibody drug aims to ease double vision and bulging eyes in thyroid disease
Disease control Recruiting nowThyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune disease closely related to thyroid disease, which leads the incidence of orbital disease in adults and is the most common cause of diffuse toxic goiter (Graves disease, GD). The clinical manifestations of TAO…
Phase 4 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:04 UTC
-
New hope for advanced liver cancer: particle beam plus immunotherapy trial launches
Disease control Recruiting nowIn the present study, we aim to investigate the efficacy and safety of concurrent therapy of Immunotherapy based combination therapy and Radiotherapy in patients with advanced HCC showing macrovascular invasion.
Phase 2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New radioactive beads aim to outperform standard liver cancer therapy
Disease control OngoingThe goal of this clinical trial is to evaluate the efficacy and safety of NRT6003 Injection compared to cTACE in patients with unresectable HCC.
Phase 3 • Sponsor: Chengdu New Radiomedicine Technology Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC